Publications by authors named "Kim Maratea"

Claim this Profile
Q
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression.
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, Anna Przybyla, Matthew Sung, Kim Maratea

CPT Pharmacometrics Syst Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma.
Nicolas Floc'h, Susan Ashton, Douglas Ferguson, Paula Taylor, Larissa S Carnevalli, Kim Maratea

Mol Cancer Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human 3D Gastrointestinal Microtissue Barrier Function As a Predictor of Drug-Induced Diarrhea.
Matthew F Peters, Tim Landry, Carmen Pin, Kim Maratea, Cortni Dick

Toxicol Sci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cells Lacking the Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival.
Matthew G Oser, Raquel Fonseca, Abhishek A Chakraborty, Rachel Brough, Alexander Spektor, Kim Maratea

Cancer Discov· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles.
Nicolas Floc'h, Susan Ashton, Paula Taylor, Dawn Trueman, Emily Harris, Kim Maratea

Mol Cancer Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis